CN
Alamar NULISA

The NULISA™ Platform sets a new standard in proteomic analysis with attomolar sensitivity, allowing for unprecedented biomarker detection and quantitation.

By leveraging a proprietary sequential immunocomplex capture and release mechanism and the latest advances in Next-Generation Sequencing (NGS), the NULISA technology provides both ultra-high sensitivity and scalable multiplexing.

Protein marker library

Fully Automated Workflow

Single-plex results in <8 hours and multiplex results in <15 hours with <30 minutes total hands-on time with the ARGO™ HT System

Single-plex Workflow

Multiplex Workflow

Application Cases
  • ULTRA HIGH SENSITIVTY
    Raising the Bar by Lowering the Limit (of Detection)
  • BROAD DYNAMIC RANGE
    Measuring Changes Across the Biological Spectrum
  • FLEXIBLE PLEX
    Scaling from Single-plex to Multiplex

Panel

Customised
Services

COPYRIGHT©Infinity Scope Multi-Omics Biotechnology Co. Ltd., All rights reserved. 浙ICP备2023015471号-1